Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

ABS82 Anti-VEGF Antibody

ABS82
100 µg  
Purchase on Sigma-Aldrich

Special Offers

Overview

Replacement Information

Key Spec Table

Species ReactivityKey ApplicationsHostFormatAntibody Type
M, R, HWB, IH(P)RbAffinity PurifiedPolyclonal Antibody
Description
Catalogue NumberABS82
Replaces07-1376
DescriptionAnti-VEGF Antibody
Alternate Names
  • vascular endothelial growth factor A
  • vascular endothelial growth factor
  • Vascular permeability factor
  • vascular endothelial growth factor isoform VEGF
Background InformationVascular endothelial growth factor A (UniProt: P15692; also known as VEGF-A, Vascular permeability factor, VPF) is encoded by the VEGFA (also known as VEGF) gene (Gene ID: 7422) in human. VEGF is a disulfide-linked homodimeric protein that acts as one of the most potent angiogenic cytokines to regulate vascular proliferation and permeability. It also acts as an anti-apoptotic factor for newly formed blood vessels. It is synthesized with a signal peptide (aa 1-26), which is subsequently cleaved off to generate the mature form. Alternative splicing of a single VEGF gene generates five isoforms known as VEGF 121, 145, 165, 189 and 206, which differ in their molecular weights and in their ability to bind to cell-surface heparan sulfate proteoglycans. VEGF121 and VEGF165 are reported to be the most dominant forms expressed in all tumor cell lines investigated. VEGF121 is acidic and is freely secreted. However, VEGF165 is more basic, has heparin-binding properties and, although a significant proportion remains cell-associated, most is freely secreted. The biological effects of VEGF are mediated through two VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1), whose expression is largely, limited to the vascular endothelium. VEGF expression is enhanced in response to hypoxia, oncogenes, and other cytokines, and is associated with poor prognosis in several types of cancer.
References
Product Information
FormatAffinity Purified
HS Code3002 15 90
Control
  • HuVec cell lysate
PresentationPurified rabbit polyclonal antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Quality LevelMQ100
Applications
ApplicationAnti-VEGF, Cat. No. ABS82, is a rabbit polyclonal antibody that detects Vascular endothelial growth factor (VEGF) and is tested for use in Immunohistochemistry (Paraffin), and Western Blotting.
Key Applications
  • Western Blotting
  • Immunohistochemistry (Paraffin)
Application NotesTested Applications

Immunohistochemistry (Paraffin) Analysis: A 1:200 dilution from a representative lot detected VEGF in human placenta tissue sections.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Biological Information
ImmunogenKLH-conjugated linear peptide corresponding to 20 amino acids from the N-terminal region of human vascular endothelial growth factor A (VEGF-A).
EpitopeN-terminus
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostRabbit
SpecificityThis antibody recognizes VEGF at the N-terminus.
Species Reactivity
  • Mouse
  • Rat
  • Human
Species Reactivity NoteHuman, Mouse, Rat. Predicted to react with Primate based on 100% sequence homology.
Antibody TypePolyclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThis gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms. [provided by RefSeq].
Gene Symbol
  • VPF
  • VEGF-A
  • MVCD
  • VEGF
  • VEGA
Purification MethodAffinity Purfied
UniProt Number
UniProt SummaryFUNCTION: Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis, and induces permeabilization of blood vessels. Binds to the VEGFR1/Flt-1 and VEGFR2/Kdr receptors, heparan sulfate and heparin. Neuropilin-1 binds isoforms VEGF-165 and VEGF-145.

SUBUNIT: Homodimer; disulfide-linked. Also found as heterodimer with PlGF (By similarity).

SUBCELLULAR LOCATION: Secreted. Note=VEGF121 is acidic and freely secreted. VEGF165 is more basic, has heparin-binding properties and, although a signicant proportion remains cell-associated, most is freely secreted. VEGF189 is very basic, it is cell-associated after secretion and is bound avidly by heparin and the extracellular matrix, although it may be released as a soluble form by heparin, heparinase or plasmin.

ALTERNATIVE PRODUCTS: 10 named isoforms [FASTA] produced by alternative splicing.
Molecular Weight~ 57 kDa observed; 17.22 to 45.46 kDa calculated for various isoforms. Uncharacterized bands may be observed in some lysate(s).
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Western Blotting in Human umbilical vein endothelial cells (HUVEC) lysate.

Western Blotting Analysis: A 1:2,000 dilution of this antibody detected VEGF in Human umbilical vein endothelial cells (HUVEC) lysate.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsRecommend storage at +2°C to +8°C. For long term storage antibodies can be kept at -20°C . Avoid repeated freeze-thaws.
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
ABS82 04053252289798

Documentation

Anti-VEGF Antibody SDS

Title

Safety Data Sheet (SDS) 

Anti-VEGF Antibody Certificates of Analysis

TitleLot Number
Anti-VEGF (rabbit polyclonal) - 3707444 3707444
Anti-VEGF (rabbit polyclonal) - 3925337 3925337
Anti-VEGF (rabbit polyclonal) - 4158968 4158968
Anti-VEGF - 2142671 2142671
Anti-VEGF - 2370846 2370846
Anti-VEGF - 2436810 2436810
Anti-VEGF - 2452470 2452470
Anti-VEGF - 2461591 2461591
Anti-VEGF - 1956737 1956737
Anti-VEGF - 2009447 2009447

References

Reference overviewPub Med ID
Akt/hypoxia-inducible factor-1α signaling deficiency compromises skin wound healing in a type 1 diabetes mouse model.
Jing, L; Li, S; Li, Q
Experimental and therapeutic medicine  9  2141-2146  2015

Show Abstract
26136949 26136949
Effects of prenatal hypoxia on schizophrenia-related phenotypes in heterozygous reeler mice: a gene × environment interaction study.
Howell, KR; Pillai, A
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology  24  1324-36  2014

Show Abstract
24946696 24946696
Airway administration of vascular endothelial growth factor siRNAs induces transient airspace enlargement in mice.
Takahashi, Y; Izumi, Y; Kohno, M; Ikeda, E; Nomori, H
International journal of medical sciences  10  1702-14  2013

Show Abstract
24155658 24155658
Amount of torque and duration of stretching affects correction of knee contracture in a rat model of spinal cord injury.
Moriyama, H; Tobimatsu, Y; Ozawa, J; Kito, N; Tanaka, R
Clinical orthopaedics and related research  471  3626-36  2013

Show Abstract
23893364 23893364
A bioreactor for subjecting cultured cells to fast-rate intermittent hypoxia.
Theodora Tsapikouni,Elena Garreta,Esther Melo,Daniel Navajas,Ramon Farré
Respiratory physiology & neurobiology  182  2012

Show Abstract
22246085 22246085
Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle.
Carlos Hermano da Justa Pinheiro,Jean César Farias de Queiroz,Lucas Guimarães-Ferreira,Kaio Fernando Vitzel,Renato Tadeu Nachbar,Luís Gustavo Oliveira de Sousa,Alcione Lescano de Souza-Jr,Maria Tereza Nunes,Rui Curi,Carlos Hermano da Justa Pinheiro,Jean C de Queiroz,Lucas Guimar,Lu de Sousa
Stem cell reviews  8  2012

Show Abstract
21874281 21874281

Related Products & Applications

Related Products

Catalogue Number Description
05-1116 Anti-VEGF Antibody, clone CH-10
05-1117 Anti-VEGF Antibody, clone VG1
05-443 Anti-VEGF Antibody, clone JH
07-1420 Anti-VEGF Antibody
ABS82-AF488 Anti-VEGF Antibody, Alexa Fluor® 488 Conjugate
ABS82-AF647 Anti-VEGF Antibody, Alexa Fluor® 647 Conjugate
MABC595 Anti-VEGF 165b Antibody, clone 56/1

Alternative Packsize

Catalogue Number Description
ABS82-KC Anti-VEGF (1mg) KC

Product Families

Categories

Life Science Research > Antibodies and Assays > Primary Antibodies